DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/ttjbrg/testosterone_repla) has announced the addition of the "Testosterone Replacement Therapy (TRT) - Global Strategic Business Report" report to their offering.
“Testosterone Replacement Therapy (TRT) - Global Strategic Business Report”
This report analyzes the worldwide markets for Testosterone Replacement Therapy (TRT) in US$ Million. The global and the US markets are further analyzed by the following Product Segments: Gels, Patches, and Others. The report provides separate comprehensive analytics for the US, Canada, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2009 through 2017. Also, a six-year historic analysis is provided for these markets. The report profiles 19 companies including many key and niche players. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based upon search engine sources in the public domain.
Key Topics Covered:
I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS
II. EXECUTIVE SUMMARY
1. Outlook
2. Industry Overview
3. Product Overview
4. Competitive Analysis
5. Clinical Studies/Trials
6. Product Launches/Innovations/ Regulatory Approvals
7. Recent Industry Activity
8. Focus On Select Global Players
9. Global Market Perspective
III. MARKET
1. The United States
2. Canada
3. Europe
4. Asia-Pacific
5. Latin America
6. Rest Of World
IV. COMPETITIVE LANDSCAPE
Companies Mentioned
Some of the 19 companies mentioned include:
- Abbott Laboratories
- Acrux Limited
- Auxilium Pharmaceuticals, Inc.
- Bayer Schering Pharma AG
- Columbia Laboratories, Inc.
- Eli Lilly and Company
- Endo Pharmaceuticals, Inc.
- GlaxoSmithKline plc.
- Kyowa Hakko Kirin Co., Ltd
- ProStrakan Group PLC.
- Slate Pharmaceuticals, Inc.
- Trimel BioPharma SRL
- Watson Pharmaceuticals, Inc.
For more information, including full table of contents, please visit http://www.researchandmarkets.com/research/ttjbrg/testosterone_repla





